Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Nov 25, 2021 1:55am
585 Views
Post# 34164228

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Hemerion Planning Phase 2 Trial at Mt. Sinai NY in 2022
99942Apophis wrote: Hi 012009 if they do it wouldn't be the first specialized clinic in Canada to have patients from other countries. Wen I went to the Shouldice Hospital Toronto for my Hernia surgery I met other patients many came from Europe so it probably would be as you say open to medical tourism bringing their Euro dollars.


If there's a better option out there, people will come....especially if the option is more patient-friendly &/or competitively priced.  People will pay/travel if it means staying alive & well.  They could then return home for any additional adjuvant or maintenance radiological/medical treatments.  I also don't think such an exclusivity clause holds water...Rutherrin is chemically in a completely different class of compounds.  All imo & I'm not worried one bit.
<< Previous
Bullboard Posts
Next >>